Multicenter Study of Contraceptive Vaginal Ring (NuvaRing (®) ) in Normal Daily Practice in Indian Women
Pandit, S.N.; Chauhan, A.R.; Anagani, M.; Reddy, S.; Birla, A.; Ray, S.K.
Journal of Obstetrics and Gynaecology of India 64(6): 409-416
2014
ISSN/ISBN: 0971-9202 PMID: 25489144 DOI: 10.1007/s13224-014-0559-7Document Number: 624416
This was the first Indian multicenter study at six specialty hospitals, to assess the real-life usage of the vaginal ring in daily clinical practice. This open-label, prospective, single-arm, nonrandomized, interventional study enrolled 252 women aged >18 years, seeking contraception with no contraindications to the use of combined hormonal contraceptive. Women were provided the ring with a monthly follow-up schedule for three cycles. Cycle control, acceptability, tolerability, and safety assessments were recorded at each visit. Regular menstrual bleeding was reported by 76.2 % (192/252) at baseline. In study completers, regular bleeding was seen in 94.1 % (192/204), 97.5 % (199/204), and 98 % (200/204) in the 1st, the 2nd, and the 3rd cycles, respectively. Most (94.2 % [195/207]) women were very satisfied or satisfied with the ring, and 93.2 % (193/207) would recommend it to others. No pregnancies or serious adverse events were reported. The study demonstrated that NuvaRing(®) is a highly effective contraceptive method with an excellent cycle control. It is well tolerated and accepted by Indian women.
Document emailed within 0-6 h
